Boston Scientific Corp.’s recent filing unveils that its EVP, Global Operations Sorenson John Bradley unloaded Company’s shares for reported $1.13 million on Apr 01 ’24. In the deal valued at $69.30 per share,16,351 shares were sold. As a result of this transaction, Sorenson John Bradley now holds 50,638 shares worth roughly $3.44 million.
Then, Carruthers Wendy sold 6,983 shares, generating $477,777 in total proceeds. Upon selling the shares at $68.42, the EVP, Human Resources now owns 51,068 shares.
Before that, Mirviss Jeffrey B. sold 14,506 shares. Boston Scientific Corp. shares valued at $963,930 were divested by the EVP&Pres, Periph Intervent at a price of $66.45 per share. As a result of the transaction, Mirviss Jeffrey B. now holds 58,098 shares, worth roughly $3.95 million.
Mizuho upgraded its Boston Scientific Corp. [BSX] rating to a Buy from a a Neutral in a research note published on February 01, 2024; the price target was increased to $80 from $65. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in mid July with a ‘”an Outperform”‘ rating. CL King began covering BSX with “Buy” recommendation on June 30, 2023.
Price Performance Review of BSX
On Monday, Boston Scientific Corp. [NYSE:BSX] saw its stock jump 1.02% to $68.02. Over the last five days, the stock has gained 0.86%. Boston Scientific Corp. shares have risen nearly 17.66% since the year began. Nevertheless, the stocks have risen 29.27% over the past one year. While a 52-week high of $69.21 was reached on 04/11/24, a 52-week low of $48.35 was recorded on 01/02/24. SMA at 50 days reached $67.23, while 200 days put it at $57.59. A total of 7.66 million shares were traded, compared to the trading of 6.97 million shares in the previous session.
Levels Of Support And Resistance For BSX Stock
The 24-hour chart illustrates a support level at 67.01, which if violated will result in even more drops to 66.00. On the upside, there is a resistance level at 68.82. A further resistance level may holdings at 69.61. The Relative Strength Index (RSI) on the 14-day chart is 53.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.53, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 49.38%. Stochastics %K at 28.21% indicates the stock is a holding.
The most recent change occurred on March 29, 2023 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $57 price target.
